Retractable Technologies (RVP) AI Stock Analysis

• Market Cap: $20.65M
• Dividend Yield: N/A
• Average Volume (3M): 153.51K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.51
• Revenue Growth: -0.95%
• EPS Growth: 58.17%
• Country: US
• Employees: 221
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.01
• Shares Outstanding: 29,937,159
• 10 Day Avg. Volume: 341,920
• 30 Day Avg. Volume: 153,511
• PEG Ratio: -0.03
• Price to Book (P/B): 0.24
• Price to Sales (P/S): 0.62
• P/FCF Ratio: -1.59
• Enterprise Value/Market Cap: 0.86
• Enterprise Value/Revenue: 0.47
• Enterprise Value/Gross Profit: -19.35
• Enterprise Value/Ebitda: 12.28
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: $0.68 ▼(-6.44% Downside)
• Action: Reiterated Date: 12/31/25
• Date: Action: Reiterated 12/31/25

The score is held down primarily by weak profitability (negative margins) and negative operating cash flow despite low leverage. Technical indicators also lean bearish with the price below key moving averages and negative MACD. Valuation offers limited support because the negative P/E reflects ongoing losses, and no common dividend yield is provided.

Positive Factors

Low Leverage / Strong Balance Sheet

Extremely low debt-to-equity (0.015) provides durable financial flexibility, reducing default and refinancing risk. This allows management to fund R&D, domestic production shifts, or absorb tariff-driven cost increases without immediate reliance on costly external financing, supporting long-term resilience.

Revenue Recovery and International Growth

A return to TTM revenue growth (+13.09%) and reported international revenue gains signal renewed demand and geographic diversification. Sustained top-line recovery improves scale economics, supports product adoption in new markets, and can underpin margin improvement if maintained over multiple quarters.

Positive Free Cash Flow Growth

Free cash flow growth of ~10% is a durable indicator of improving cash generation capacity, enabling reinvestment, debt avoidance, or strategic initiatives. Even with operating cash flow weakness, rising FCF suggests management is managing capex and working capital to support longer-term operating stability.

Negative Factors

Persistent Negative Profitability

Negative gross and net margins indicate structural cost or pricing issues that erode core profitability. Continued losses limit reinvestment, constrain ability to scale, and may require pricing, product mix, or cost-structure changes to achieve sustainable operating margins over the medium term.

Negative Operating Cash Flow

Operating activities failing to generate cash is a structural concern: it implies core business doesn't convert sales into sustainable cash, increasing reliance on balance sheet actions. This can pressure liquidity and constrain investment unless operational cash conversion improves consistently.

Revenue Volatility and Unit/ASP Pressure

Reported declines in unit sales and average selling price suggest weakening pricing power and demand variability. Combined with tariff-driven production shifts, this creates durable margin pressure and operational uncertainty unless the company stabilizes unit volumes or moves to higher-margin product mix.

Retractable Technologies Business Overview & Revenue Model

Company Description

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

How the Company Makes Money

Retractable Technologies generates revenue primarily through the sale of its retractable syringes and safety needle products. The company sells these products directly to healthcare providers and distributors, establishing long-term contracts and partnerships that ensure a steady stream of orders. Additionally, RVP benefits from government contracts and participation in group purchasing organizations, which enable it to reach a broader customer base. The company may also explore partnerships with other healthcare firms to expand its product offerings or enter new markets, contributing to its overall earnings.

Retractable Technologies Financial Statement Overview

Summary

Moderate overall fundamentals: revenue returned to growth (TTM +13.09%), but profitability is weak with negative gross and net margins and deteriorating EBIT/EBITDA margins. Balance sheet leverage is low (debt-to-equity 0.015), yet negative ROE and negative operating cash flow highlight operating and cash-generation strain despite positive free cash flow growth.

Income Statement

Retractable Technologies has experienced significant revenue volatility, with a recent TTM revenue growth of 13.09% following a previous decline. However, profitability metrics are concerning, with negative gross and net profit margins in the TTM period, indicating operational challenges. The EBIT and EBITDA margins have also deteriorated, reflecting ongoing cost pressures.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.015, indicating minimal leverage risk. However, the negative return on equity in the TTM period suggests inefficiencies in generating returns from shareholders' equity. The equity ratio remains stable, highlighting a solid capital structure.

Cash Flow

Cash flow performance is mixed, with a positive free cash flow growth rate of 10.09% in the TTM period. However, negative operating cash flow and a high free cash flow to net income ratio indicate potential liquidity issues. The company needs to improve its cash generation capabilities to support operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Mar 2021
Income Statement
Total Revenue	37.90M	33.05M	43.60M	94.82M	188.38M	81.86M
Gross Profit	-917.47K	-1.03M	9.11M	28.25M	95.35M	37.01M
EBITDA	1.45M	4.17M	-1.24M	9.94M	76.44M	27.17M
Net Income	-6.45M	-11.89M	-7.01M	5.08M	56.06M	24.22M
Balance Sheet
Total Assets	146.43M	160.72M	179.67M	210.74M	213.15M	104.97M
Cash, Cash Equivalents and Short-Term Investments	33.95M	44.56M	47.29M	49.38M	42.43M	25.65M
Total Debt	988.71K	1.23M	1.54M	2.92M	4.24M	3.74M
Total Liabilities	69.65M	73.55M	80.38M	104.21M	113.98M	55.09M
Stockholders Equity	76.78M	87.17M	99.29M	106.54M	99.17M	49.88M
Cash Flow
Free Cash Flow	-8.38M	-13.00M	1.91M	-61.95K	-25.57M	-2.05M
Operating Cash Flow	-7.57M	-11.56M	2.77M	16.77M	32.79M	19.00M
Investing Cash Flow	7.66M	3.66M	-10.76M	-31.20M	-63.04M	-19.33M
Financing Cash Flow	-559.64K	-535.43K	941.64K	4.99M	41.84M	11.96M

Retractable Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.73
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Negative. The current price of 0.73 is above the 20-day moving average (MA) of 0.67, above the 50-day MA of 0.72, and below the 200-day MA of 0.77, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 41.83 is Neutral, neither overbought nor oversold. The STOCH value of 30.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RVP.

Retractable Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STXS	62 Neutral	$199.72M	-7.61	-170.24%	―	19.61%	-3.42%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
OSUR	51 Neutral	$213.77M	-3.18	-15.30%	―	-43.95%	-620.21%
RVP	48 Neutral	$20.65M	-3.09	-8.05%	―	-0.95%	58.17%
SMTI	42 Neutral	$186.22M	-4.80	-27.19%	―	30.55%	-340.19%
MLSS	42 Neutral	$22.13M	-3.40	-136.47%	―	0.59%	-39.76%

Retractable Technologies Corporate Events

Retractable Technologies Declares Dividend on Convertible Preferred Shares

On December 30, 2025, Retractable Technologies announced that it declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The dividend declaration affects this specific class of preferred shareholders and reflects a capital allocation decision that may influence investor returns and perceptions of the company’s treatment of its preferred equity holders.

The most recent analyst rating on (RVP) stock is a Hold with a $0.80 price target. To see the full list of analyst forecasts on Retractable Technologies stock, see the RVP Stock Forecast page.

Retractable Technologies Reports Q3 2025 Financial Results

On November 14, 2025, Retractable Technologies reported its financial results for the third quarter of 2025, showing net sales of $10.1 million and an operating loss of $3.7 million, compared to $10.3 million in sales and a $5.1 million loss in the same period last year. The company has been impacted by tariffs on imported products, leading to increased domestic production, which now accounts for 38.3% of its manufacturing. Despite a decrease in overall unit sales, the company improved its gross margin due to a favorable product mix and reduced tariff costs. International revenues increased by 25% for the quarter, although the average selling price declined. Retractable also received an Innovative Technology designation from Vizient®.

The most recent analyst rating on (RVP) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Retractable Technologies stock, see the RVP Stock Forecast page.